➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Boehringer Ingelheim
Merck
Colorcon
Mallinckrodt

Last Updated: December 1, 2020

DrugPatentWatch Database Preview

Claims for Patent: 4,692,404

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,692,404
Title: Method of measuring biological ligand by the use of enzymes
Abstract:A method is provided which is highly sensitive and specific, and is suitable as a clinical test for the determination of physiological substances and trace components in humoral fluid. The method employs a conjugate of an enzyme capable of acting on a water-insoluble macromolecular substance and an antibody against the ligand (1) to be measured or a ligand (2) having an antigenic determinant common to one of the antigenic determinant(s) of the ligand (1). In the method of the invention, steric hindrance of the conjugate is emphasized by the enzyme reaction which is carried out at the boundary between solid phase and liquid phase.
Inventor(s): Ashihara; Yoshihiro (Tokyo, JP), Kasahara; Yasushi (Tokyo, JP)
Assignee: Fujirebio Kabushiki Kaisha (Tokyo, JP)
Application Number:06/670,764
Patent Claims:1. A method of determining a biological ligand which comprises,

using an antibody or ligand binding fragments thereof, against the ligand to be measured and an enzyme capable of acting on a water-insoluble macromolecular substrate and which conjugates with said antibody or ligand binding fragments thereof,

contacting said antibody or ligand binding fragments thereof, with said ligand,

contacting said enzyme with a water-insoluble macromolecular substrate, and

thereafter measuring the change in activity of the enzyme after it has acted on said substrate, relating said change in the activity of the enzyme to the concentration of the ligand.

2. The method of claim 1, wherein said ligand (1) and said ligand (2) are the same.

3. A method of determining a biological ligand using an antibody or ligand binding fragment thereof against the ligand (1) to be measured and an enzyme capable of acting on a water-insoluble macromolecular substrate and which conjugates with

a ligand (2) having an antigenic determinant common to one of the antigenic determinant(s) of said ligand (1), which method comprises:

contacting said antibody or ligand binding fragment thereof with said ligands (1) and (2),

contacting said enzyme with a water-insoluble macromolecular substrate, and

thereafter measuring the change in activity of the enzyme after it has acted on said substrate, relating said change in the activity of the enzyme to the concentration of the ligand (1).

4. The method of claim 1 or claim 3, wherein said antibody or ligand binding fragments thereof conjugates with a macromolecular compound which is water-soluble and which has a molecular weight greater than 100,000 daltons.

5. The method of claim 1 or claim 3, wherein said ligand is a member selected from the group consisting of hormones derived from endocrine glands, plasma proteins, viral antigens, bacteria, .alpha.-fetoprotein, and carcinoembryonic antigens.

6. The method of claim 1 or claim 3, wherein said antibody is a monoclonal antibody.

7. The method of claim 1 or claim 3, wherein said enzyme is a member selected from the group consisting of .alpha.-amylase, cellulase, collagenase, mannase, protease, elastase, and lipase.

8. The method of claim 7, wherein said macromolecular substance is insoluble starch and said enzyme is .alpha.-amylase.

9. The method of claim 7 wherein said macromolecular substance is cellulose and said enzyme is cellulase.

10. The method of claim 7 wherein saidmacromolecular substance is collagen and said enzyme is collagenase.

11. The method of claim 7 wherein said macromolecular substance is mannan and said enzyme is mannase.

12. The method of claim 7 wherein said macromolecular substance is an insoluble protein and said enzyme is protease.

13. The method of claim 7 wherein said macromolecular substance is elastin and said enzyme is elastase.

14. The method of claim 7 wherein said macromolecular substance is lipid and said enzyme is lipase.

Summary for Patent:   Start Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan58-217145Nov 18, 1983
Japan58-231241Dec 09, 1983

Details for Patent 4,692,404

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial Fujirebio Kabushiki Kaisha (Tokyo, JP) 2003-11-18 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Mallinckrodt
Harvard Business School
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.